Share This

Related Topics News -

     
 Title only   |   Print 
     
《大行》里昂調整醫藥股目標價 內地CXO及創新藥物表現亮麗

2025-04-08T  
《業績》固生堂全年純利3.07億人民幣增21.6% 末期息派41港仙

2025-04-01T  
《大行》大摩:市場憂慮中藥片劑帶量採購擴至私營醫院 如落實料影響固生堂北京業務毛利率約3個百分點

2025-03-12T  
《大行》匯豐研究對醫藥股投資評級及目標價(表)

2025-01-06T  
《大行》匯豐研究:內地製藥及醫療器材子產業能見度提高 偏好百濟神州、中生製藥及海吉亞醫療等

2025-01-06T  
固生堂行使購回股份授權 總價最多2億元

2024-11-24T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.